Definitive Contract 75N93023C00051
Award Date
9/22/23
Potential Completion Date
12/31/25
Potential Value
$3.7M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Arisan Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,314,726 delivery order to Sri International, a non-profit research institute, to provide pre-clinical microbiological, safety, toxicology, and pharmacokinetic services. This order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery, indefinite quantity (IDIQ) contract. The period of performance runs through April...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,668,608 cost plus fixed fee delivery order contract to Sri International for pre-clinical, microbiological, safety, toxicology, and pharmacokinetic services. Sri International will perform this work in West Menlo Park, California from February 15, 2023 through February 14, 2024. Bioivt, LLC will provide transporter studies services and Charles River...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $443,000 delivery order against the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract to Curia Global Inc., doing business as Amri. This firm fixed price order is for non-clinical services and will be performed in Spain from September 14, 2022 through December...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $451,555 delivery order contract to Sri International under the master indefinite-delivery indefinite-quantity contract titled "Nonclinical Services for Development of Interventional Agents." The contract is for Sri International to provide nonclinical services for the development of interventional agents for infectious diseases from September 1,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2.27 million delivery order contract to Sri International under the prime contractor's existing Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity master contract. The 24-month contract calls for Sri International to provide nonclinical services for the development of interventional agents to address...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is a Delivery Order under the In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. The $1,275,123.00 cost-plus-fixed-fee contract is for evaluating therapeutic product...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $63,336 firm fixed price delivery order against the Nonclinical Services for Development of Interventional Agents master IDIQ to Sri International. The order is for nonclinical services to support the development of interventional agents for infectious diseases. Performance will take place in West Menlo Park, California over a one year period ending December...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.3 million delivery order contract to Sri International of West Menlo Park, California under the master indefinite-delivery indefinite-quantity contract titled Nonclinical Services for Development of Interventional Agents. The 24-month cost-plus-fixed-fee contract provides nonclinical services for the development of interventional agents for infectious diseases to support the Department of...
This task order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Sri International for $1.3 million to conduct toxicology studies of tenofovir nanoformulation with pharmacokinetics in mice, inhalation toxicity studies of clofazimine in rats, and support development of mitochondrial toxicity assays for mitochon. The prime contractor will perform the work in West Menlo Park, California over a 15-month period ending in October 2021. The...